Skip to main content

Table 1 Demograhics

From: Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial

 

SBRT group n = 27

3DCRT group n = 28

p-value

n

%

n

%

 

Age (years)

 Mean (SD)

61 (8,2)

 

63,9 (10,8)

 

0,225

Gender

 Male

15

55,6

13

46,4

0,499

 Female

12

44,4

15

53,6

 

 Weight (kg, SD)

76 (19,2)

 

78,2 (16,4)

  

 Height (cm, SD)

171,1 (8,5)

 

172,3 (8,7)

  

Body mass index (BMI)

 Mean (SD)

25,8 (5,8)

 

26,5 (5,7)

 

0,899

Primary site

 Lung cancer

9

33,3

10

35,7

 

 Breast cancer

7

26,3

10

35,7

 

 Renal cancer

2

7,4

2

7,1

 

 Other

9

33,3

6

21,4

 

 Localization metastases

    

0,317

 Thoracic

14

51,9

19

67,9

 

 Lumbar

13

48,1

8

28,6

 

 Number metastases

    

0,301

 1 metastasis

24

88,9

22

78,6

 

 2 metastases

3

11,1

6

21,4

 

Distant metastases at baseline

 Viszeral

12

44,4

14

51,9

0,586

 Lung

11

40,7

4

14,8

0,033

 Brain

7

25,9

3

11,1

0,161

 Tissue

5

18,5

4

14,8

0,715

 Hormontherapy

6

22,2

8

28,6

0,589

 Immuntherapy

8

29,6

8

28,6

0,931

 Chemotherapy

11

40,7

13

46,4

0,671

 Surgery

8

29,6

10

35,7

0,631

 Neurological deficit at baseline

0

0

1

3,6

0,322

 Bisphosphonate at baseline

11

40,7

13

46,4

0,671

 Orthopedic corset at baseline

3

11,1

6

21,4

0,301

Medication at baseline

 Sleeping medication

1

3,7

1

3,6

0,979

 Psychiatric medication

3

11,1

5

17,9

0,478

 Opiate

11

40,7

10

35,7

0,701

 NSAID

15

55,6

15

53,6

0,883

  1. Baseline characteristics of randomly assigned participants. Explanation: Others: cholangiocarcinoma, carcinoma of unknown primary, colon cancer, hepatocellular carcinoma, melanoma cancer, pancreatic cancer, neuroendocrine cancer, prostate cancer, urothelial cancer
  2. Abbreviations: NSAID nonsteroidal inflammatory drug